July 11, 2025

Tariff Extensions

President Trump extended the effective date of the country-specific reciprocal tariffs until August 1, 2025, except for China, which already has an extension date of August 12, 2025. U.S. Customs and Border Protection (CBP) issued official guidance (CSMS #65573545) on the extensions on July 8, 2025.

Tariff Amendments

On July 7, 2025, the White House announced the following adjustments from the original country-specific tariff amounts for the countries below, which are scheduled to go into effect after August 1, 2025, unless there is a further adjustment or extension.

  • Bangladesh (35%)
  • Bosnia and Herzegovina (30%)
  • Cambodia (36%)
  • Indonesia (32%)
  • Japan (25%)
  • Kazakhstan (25%)
  • Korea (25%)
  • Laos (40%)
  • Malaysia (25%)
  • Myanmar (40%)
  • Serbia (35%)
  • South Africa (30%)
  • Thailand (36%)
  • Tunisia (25%)

Brazil Tariffs (Announced)

(50%) – On July 9, 2025, President Trump announced that the U.S. would be implementing a 50% tariff on all Brazilian goods imported into the U.S., effective August 1, 2025. The Brazilian government vows to match any U.S. tariffs imposed.

Canada Tariffs (Announced)

(35%) – On July 10, 2025, the President mentioned in an interview that he plans to increase Canadian tariffs to 35% next month.

Copper Tariffs (Announced)

(50%) – In a Cabinet meeting this week, the President commented, “I believe the tariff on copper, we’re going to make it 50%.” Thus far, there is no announced date of implementation.

Tariffs – All Other Countries (Announced)

In an interview this week, the President alluded to increasing the current 10% global baseline blanket tariff to 15% – 20%. A set date was not commented on.

FDA Rescinds Low-Value Shipment Exemption

Effective immediately, the FDA has rescinded its de minimis exemption for low-value shipments. This means all FDA-regulated products, regardless of value, must now be submitted for FDA review. This change overrides all previous guidance that allowed some low-value shipments to be released without review

Categories:

Tags:

Comments are closed